Mark Baxter
@drmarkbaxter.bsky.social
Clinical Senior Lecturer in Medical Oncology University of Dundee | Honorary NHS Consultant | Research - frailty, geriatric oncology, precision medicine in UGI/HPB cancer.
Reposted by Mark Baxter
📣 Check out this recent study:
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
Objective The Cancer and Aging Research Group (CARG) score was developed to predict severe chemotherapy-induced toxicity risk in older adults; validation study results have varied. The Tolerance of An...
bmjoncology.bmj.com
November 28, 2024 at 1:33 PM
📣 Check out this recent study:
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy